Market Place
Sourcing Support
DMF submissions from China jump 42% as India continues to top list in Q1 2024
Generic drugs play a crucial role in providing access to life-saving drugs at affordable prices. To
DMF submissions in 2021: India, China continue to top filings
The year
2021 was eclipsed by the Covid-19 pandemic. In our update for the first half of 2020, we h
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
DMF submissions in 2019: India maintains bulk drug supply supremacy to US
At PharmaCompass, we highlighted
the significance of India in the global active pharmaceutical ingr
US market offers niche opportunities, reveals manufacturer sales data from Medicare Part D
This week, PharmaCompass reviews the recently released data of the Medicare Part D Prescription Drug
Mylan’s President, Emcure’s CEO named in US drug price-fixing probe; Novartis buys French biotech for US$ 3.9 billion
This week in Phispers, we look at how Mylan’s president Rajiv Malik and Emcure’s CEO Sat
India-China border tension may impact billion dollar pharma deal; AZ’s investors worry as key cancer drug fails trial
This week in Phispers, we analyze the
situation at AstraZeneca, where its much anticipated lung canc
Ghosts of GSK’s billion dollar mistake return; New date for electronic submissions of DMFs
This week, Phispers tells us why David Hung’s taking charge as CEO of Axovant could signal the
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the
President of the United States. He
Phispers: Pfizer-Allergan end megamerger, GSK wants to make copying its drugs easier & more
This week, the
biggest news in the world of pharmaceuticals was the termination of the Pfizer-Allerg
